A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment
Abstract The number of individuals with chronic kidney disease (CKD) is increasing worldwide, including in Japan. Patients with advanced CKD are at an increased risk of serious adverse drug events associated with hospitalization, life-threatening complications, and death. It is necessary to adjust t...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Journal of Pharmaceutical Health Care and Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40780-025-00431-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849734760753004544 |
|---|---|
| author | Akihiro Sonoda |
| author_facet | Akihiro Sonoda |
| author_sort | Akihiro Sonoda |
| collection | DOAJ |
| description | Abstract The number of individuals with chronic kidney disease (CKD) is increasing worldwide, including in Japan. Patients with advanced CKD are at an increased risk of serious adverse drug events associated with hospitalization, life-threatening complications, and death. It is necessary to adjust the dosage of renally excreted drugs according to kidney function in patients with CKD. In addition, elderly patients and those with impaired kidney function are also at high risk of drug-induced nephrotoxicity due to nephrotoxic drugs, and special attention should be paid to changes in kidney function before and after administration. Hospitalized patients are more susceptible to acute kidney injury than outpatients, and care must be taken when administering renally excreted or nephrotoxic drugs. Clinical decision support systems (CDSSs) play an important role in preventing overdosage of renally excreted drugs and avoiding the inappropriate use of nephrotoxic drugs. This review discussed the effectiveness, issues, and potential of CDSSs for physicians’ prescriptions and pharmacists’ prescription audits before hospitalized patients with kidney impairment are administered renally excreted drugs or nephrotoxic drugs, and the follow-up of patients receiving them. Although inappropriate prescriptions of renally excreted drugs due to alerts to prescribers were reduced, prescribers may have ignored interruption alerts. Therefore, the acceptance rate of alerts by prescribers can be improved by minimizing interruptions to the prescriber workflow, specifying only high-severity alerts, and automatically inputting the dosage, administration frequency, and administration duration according to kidney function when the prescriber selects a drug when entering a prescription. Prescription audits by pharmacists using electronic alerts from the CDSS and dosage confirmation sheets were effective in preventing overdosing of renally excreted drugs. In addition, pharmacist interventions for patients at risk of acute kidney injury (AKI) using CDSS alerts may be useful in preventing a decrease in kidney function and the onset of AKI due to nephrotoxic drugs. Although the usefulness of CDSSs may be further improved in the future, further evaluation and improvement of CDSSs are required. |
| format | Article |
| id | doaj-art-afb7965d625a46f8aaebf811a5db2b18 |
| institution | DOAJ |
| issn | 2055-0294 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Pharmaceutical Health Care and Sciences |
| spelling | doaj-art-afb7965d625a46f8aaebf811a5db2b182025-08-20T03:07:43ZengBMCJournal of Pharmaceutical Health Care and Sciences2055-02942025-04-0111111010.1186/s40780-025-00431-8A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairmentAkihiro Sonoda0Department of Pharmacy, Izumi Regional Medical CenterAbstract The number of individuals with chronic kidney disease (CKD) is increasing worldwide, including in Japan. Patients with advanced CKD are at an increased risk of serious adverse drug events associated with hospitalization, life-threatening complications, and death. It is necessary to adjust the dosage of renally excreted drugs according to kidney function in patients with CKD. In addition, elderly patients and those with impaired kidney function are also at high risk of drug-induced nephrotoxicity due to nephrotoxic drugs, and special attention should be paid to changes in kidney function before and after administration. Hospitalized patients are more susceptible to acute kidney injury than outpatients, and care must be taken when administering renally excreted or nephrotoxic drugs. Clinical decision support systems (CDSSs) play an important role in preventing overdosage of renally excreted drugs and avoiding the inappropriate use of nephrotoxic drugs. This review discussed the effectiveness, issues, and potential of CDSSs for physicians’ prescriptions and pharmacists’ prescription audits before hospitalized patients with kidney impairment are administered renally excreted drugs or nephrotoxic drugs, and the follow-up of patients receiving them. Although inappropriate prescriptions of renally excreted drugs due to alerts to prescribers were reduced, prescribers may have ignored interruption alerts. Therefore, the acceptance rate of alerts by prescribers can be improved by minimizing interruptions to the prescriber workflow, specifying only high-severity alerts, and automatically inputting the dosage, administration frequency, and administration duration according to kidney function when the prescriber selects a drug when entering a prescription. Prescription audits by pharmacists using electronic alerts from the CDSS and dosage confirmation sheets were effective in preventing overdosing of renally excreted drugs. In addition, pharmacist interventions for patients at risk of acute kidney injury (AKI) using CDSS alerts may be useful in preventing a decrease in kidney function and the onset of AKI due to nephrotoxic drugs. Although the usefulness of CDSSs may be further improved in the future, further evaluation and improvement of CDSSs are required.https://doi.org/10.1186/s40780-025-00431-8Acute kidney injuryClinical decision support systemChronic kidney diseaseKidney impairmentHospitalized patientsNephrotoxic drugs |
| spellingShingle | Akihiro Sonoda A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment Journal of Pharmaceutical Health Care and Sciences Acute kidney injury Clinical decision support system Chronic kidney disease Kidney impairment Hospitalized patients Nephrotoxic drugs |
| title | A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment |
| title_full | A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment |
| title_fullStr | A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment |
| title_full_unstemmed | A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment |
| title_short | A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment |
| title_sort | clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment |
| topic | Acute kidney injury Clinical decision support system Chronic kidney disease Kidney impairment Hospitalized patients Nephrotoxic drugs |
| url | https://doi.org/10.1186/s40780-025-00431-8 |
| work_keys_str_mv | AT akihirosonoda aclinicaldecisionsupportsystempromotestheappropriateuseofdrugsinhospitalizedpatientswithkidneyimpairment AT akihirosonoda clinicaldecisionsupportsystempromotestheappropriateuseofdrugsinhospitalizedpatientswithkidneyimpairment |